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Abstract
Aim/hypothesis Dietary polyphenols and long chain n-3 poly-
unsaturated fatty acids (LCn3) are associated with lower car-
diovascular risk. This may relate to their influence on glucose
metabolism and diabetes risk.We evaluated the effects of diets
naturally rich in polyphenols and/or LCn3 of marine origin on
glucose metabolism in people at high cardiometabolic risk.
Methods According to a 2×2 factorial design, individuals
with high waist circumference and at least one more compo-
nent of the metabolic syndrome were recruited at the obesity
outpatient clinic. Eighty-six participants were randomly
assigned by MINIM software to an isoenergetic diet: (1) con-
trol, low in LCn3 and polyphenol (analysed n=20); (2) rich in
LCn3 (n=19); (3) rich in polyphenols (n=19); or (4) rich in
LCn3 and polyphenols (n=19). The assigned diets were
known for the participants and blinded for people doing mea-
surements. Before and after the 8 week intervention, partici-
pants underwent a 3 h OGTT and a test meal with a similar
composition as the assigned diet for the evaluation of plasma
glucose, insulin and glucagon-like peptide 1 (GLP-1)
concentrations, and indices of insulin sensitivity and beta cell
function.
Results During OGTT, polyphenols significantly reduced
plasma glucose total AUC (p=0.038) and increased early in-
sulin secretion (p=0.048), while LCn3 significantly reduced
beta cell function (p=0.031) (two-factor ANOVA). Moreover,
polyphenols improved post-challenge oral glucose insulin
sensitivity (OGIS; p=0.05 vs control diet by post hoc
ANOVA). At test meal, LCn3 significantly reduced GLP-1
total postprandial AUC (p<0.001; two-factor ANOVA).
Conclusion/interpretation Diets naturally rich in polyphenols
reduce blood glucose response, likely by increasing early in-
sulin secretion and insulin sensitivity. These effects may
favourably influence diabetes and cardiovascular risk. The
implications of the decrease in insulin secretion and postpran-
dial GLP-1 observed with diets rich in marine LCn3 need
further clarification.
Trial registration: ClinicalTrials.gov NCT01154478
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Introduction
Dietary polyphenols and long chain n-3 polyunsaturated fatty
acids (LCn3) are associated with lower cardiovascular disease
(CVD) risk [1, 2]. Alterations of glucose metabolism are in-
volved in the pathogenesis of CVD [3]; therefore, diets rich in
polyphenols and/or LCn3 may have a favourable impact on
CVD also by improving glucose metabolism.
Several epidemiological studies have shown that dietary
intake of polyphenols was inversely related to risk of type 2
diabetes [4–6]. Numerous in vitro and animal studies also
support this finding, reporting beneficial effects of dietary
polyphenols on carbohydrate digestion, and insulin sensitivity
and secretion through the activation of various intracellular
molecular pathways [7]. Few clinical trials have explored this
issue in humans, mostly confirming beneficial effects of either
supplementation with extracts from foods rich in polyphenols
[8], or regular consumption for a short period of single foods
(green tea, chocolate, red wine etc.) [9, 10]. Therefore, infor-
mation about the efficacy of nutritional interventions, repro-
ducing real-life conditions, based on various natural foods rich
in polyphenols is lacking. This evidence would be relevant
because a holistic dietary approach including a huge variety
of food choices would be feasible and therefore applicable in
practical care. Moreover, because polyphenols differ in terms
of bioavailability and intermediate metabolism, the simulta-
neous intake of different classes of these compounds could
differently influence glucose metabolism compared with the
intake of single supplements or foods leading to an enhanced
clinical effect.
Several trials have explored the effects of short- and
medium-term LCn3 supplementation on surrogate markers
of type 2 diabetes risk, i.e. insulin sensitivity, insulin secretion,
fasting blood glucose concentrations in different populations,
and have found beneficial, detrimental or no effects [11–15].
Only a few studies have evaluated the effects on glucose me-
tabolism of LCn3 derived from dietary fish intake. They
showed an improvement in insulin sensitivity when fish con-
sumption was associated with calorie restriction [16] or phys-
ical training [17], while no effect on glucose metabolism was
observed following an isocaloric dietary intervention with fish
[18].
Against this background, the aim of our randomised clini-
cal trial was to explore, in individuals at risk of type 2 diabetes,
the medium-term effects of diets naturally rich in different
sources of polyphenols and/or marine LCn3s on glucose
metabolism.
Methods
Participants
Eighty-six individuals of both sexes, aged 35–70 years, with
overweight or obesity (BMI 27–35 kg/m2), high waist circum-
ference (men >102 cm and women >88 cm) and meeting at
least one or more criteria for the metabolic syndrome diagno-
sis according to the National Cholesterol Education Program
(NCEP)/Adult Treatment Program (ATP) III [19] were recruit-
ed at the obesity outpatient clinic of the Federico II University
Hospital (Naples, Italy). Exclusion criteria were: fasting
plasma triacylglycerols ≥4.5 mmol/l, fasting cholesterol
>7 mmol/l, cardiovascular events (myocardial attack or stroke)
during the 6 months prior to the study, established diabetes
mellitus, regular intensive exercise, renal and liver failure, or
any other chronic disease, or use of drugs able to influence
inflammation, and lipid and glucose metabolism. The partici-
pants had stable food habits, were not vegetarians and were
asked to refrain from any dietary supplement for 1 month prior
to and during the study. Inclusion and exclusion criteria were
assessed by interviews, clinical examination and routine labo-
ratory tests. Diabetes status was excluded by a 75 g OGTT.
Eight participants, equally distributed in the four experi-
mental groups, did not undergo the final test for work- or
family-related reasons. The main clinical characteristics of
the 78 participants who completed the dietary intervention
are shown in Table 1.
The design of the trial was approved by the Federico II
University Ethics Committee, complied with the Helsinki
Dec l a r a t i on gu ide l i ne s , and was r eg i s t e r ed a t
ClinicalTrials.gov registration number NCT01154478. All
participants provided written informed consent. The results
of this dietary intervention trial on lipid metabolism have been
previously published [20], and this previous publication in-
cludes a participant flow chart.
Study design
During a 3 week run-in period the participants were stabilised
on their habitual diet. Their isoenergetic requirements were
determined taking into account the individual’s habitual ener-
gy intake, evaluated by a 7 day food record, adjusted for body
weight and the dietitian’s clinical evaluation. Thereafter, they
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were randomised to follow an 8 week experimental diet ac-
cording to a 2×2 factorial design, as previously described in
detail [20]. Patients were aware of which diet group they had
been assigned to. Diets were isoenergetic and only differed for
the amount of polyphenol and LCn3: (1) Control diet (Con-
trol), low in LCn3 and polyphenols (1.5 g and 365 mg/day,
respectively); (2) High LCn3 diet (High LCn3), rich in LCn3
and low in polyphenols (4 g and 363 mg/day, respectively);
(3) High polyphenol diet (High PP), low in LCn3 and rich in
polyphenols (1.4 g and 2,903 mg/day, respectively); (4) High
LCn3 and high polyphenol diet (High LCn3&PP), rich in
LCn3 and polyphenols (4 g and 2,861 mg/day, respectively).
They were, instead, similar for other macronutrients and
micronutrients as reported in our previous paper [20]. Similar
amounts of olive oil were used as seasoning in all diets, with
the only difference being that extra-virgin olive oil was used in
the polyphenol-rich diets and non-extra-virgin olive oil in the
polyphenol-poor diets. Therefore, the diets differed for the
polyphenol content of olive oil (higher in the extra-virgin olive
oil) and not for the other olive oil components.
The main dietary sources of LCn3 were salmon, dentex and
anchovies. Polyphenols were supplied by decaffeinated green
tea and coffee, dark chocolate, blueberry jam, extra-virgin
olive oil and polyphenol-rich vegetables (artichokes, onions,
spinach and rocket). Rocket was consumed raw, while the
other vegetables were steamed, in order to reduce the effect
of the cooking process on polyphenol availability [21]. The
main polyphenol classes were flavonoids (57%)—mainly rep-
resented by flavanols (41%)—and phenolic acids (43%). The
polyphenol content of foods was measured by the Folin–
Ciocalteu method [22] or calculated according to US Depart-
ment of Agriculture (USDA) tables [23], and LCn3 levels
were calculated from the Italian Food Composition Database
[24]. No alcohol was allowed during the study. To improve
dietary compliance, all meals and beverages were provided to
the participants weekly for the whole study period. Meals
were prepared under the supervision of an expert dietitian.
The participants received dietary counselling every week
and phone calls every 2–3 days. Adherence to diet was eval-
uated by a 7 day food record performed at baseline, 4 weeks
and 8 weeks.
The participants were instructed to not change their phys-
ical activity and smoking habits during the study.
Experimental procedures and laboratory methods
At baseline and after the 8 week intervention, body weight,
height and waist circumference were measured according to
standardised procedures. After a 12 h overnight fast, the par-
ticipants underwent a 75 g OGTT, with blood sampling at 0,
15, 30, 60, 90, 120, 150 and 180 min. Two days later, after a
12 h overnight fast, they underwent a test meal rich in fat with
blood sampling at 0, 60, 120, 240 and 360 min for the evalu-
ation of postprandial lipaemia. Meals were composed of rice,
butter, parmesan cheese, bresaola and white bread, with in-
takes of olive oil, salmon and decaffeinated green tea differing
in order to obtain a similar composition as the assigned diet
[20]. Blood drawn in EDTA- or EDTA and aprotinin (for the
glucagon-like peptide 1 [GLP-1] assay) tubes was centrifuged
and plasma stored at −80°C until measurement. Glucose con-
centrations were assayed by enzymatic colorimetric methods
(ABX Diagnostics, Montpellier, France) on a Cobas Mira
Autoanalyzer (ABX Diagnostics). Insulin concentrations
were measured by ELISA (DIAsource ImmunoAssays, Ni-
velles, Belgium) on a Triturus Analyzer (Diagnostics Grifols,
Barcelona, Spain). Active GLP-1 was assayed by a nonradio-
active, highly specific sandwich ELISA method (Merck-
Millipore, Darmstadt, Germany) that had 100% cross-
reactivity with active isoforms of GLP-1 (7–36 amide and
7–37 glycine extended) but no reactivity with inactive iso-
forms (9–36 amide and 9–37 glycine extended), GLP-2 or
Table 1 Baseline characteristics of the participants of the four diet groups
Control High LCn3 High PP High LCn3&PP p value (ANOVA)
Sex (M/F) 8/12 8/11 9/11 8/11
Age (years) 54±9 56±8 53±9 55±9 0.645
Body weight (kg) 87±10 86±12 87±11 84±12 0.858
BMI (kg/m2) 33±3 32±4 32±3 30±3 0.126
Waist circumference (cm) 104±7 105±10 104±9 101±8 0.601
Systolic BP (mmHg) 120±7 121±12 126±16 119±9 0.231
Diastolic BP (mmHg) 76±8 74±7 76±9 73±8 0.663
Fasting plasma glucose (mmol/l) 5.75±0.7 5.83±0.6 5.57±0.5 5.74±0.6 0.498
Fasting plasma insulin (pmol/l) 118±38 140±50 142±44 120±45 0.220
GLP-1 (pmol/l) 3.49±1.40 3.94±2.21 3.78±2.77 3.72±3.63 0.960
QUICKI 0.37±0.03 0.36±0.02 0.36±0.02 0.37±0.02 0.398
Data are means±SD
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glucagon [25]. Laboratory analyses were performed blinded
to the assigned treatment.
Calculations
Fasting insulin sensitivity was evaluated using the quantitative
insulin sensitivity check index (QUICKI) [26]. Fasting insulin
secretion capacity was calculated as the HOMA for beta cell
function [HOMA-B: (20 fasting insulin, pmol/l)/(fasting glu-
cose, mmol/l – 3.5)] [27].
During OGTT and test meal, the total AUC was calculated
by the trapezoidal method.
After glucose load, insulin action was evaluated by the
180 min oral glucose insulin sensitivity (OGIS) method [26]
and insulin secretion capacity was calculated as beta cell func-
tion [insulin 0–180 AUC/glucose 0–180 AUC ratio] [26] and
early phase insulin secretion (insulin 0–30 AUC).
Statistical analysis
The sample size (80 patients) was calculated on the primary
outcome, i.e. postprandial lipid response [20]. This sample size
was also adequate to detect a 0.3 mmol/h reduction in post-load
blood glucose AUC that corresponds to the difference previ-
ously observed in post-load glucose AUC between healthy
people and individuals at high risk of diabetes [27]. We sought
to see this difference with an 80% power at the 5% significance
level. To take care of a possible dropout, 86 participants were
enrolled. The random allocation to the intervention, stratified
for sex, age, BMI and plasma triacylglycerols was performed
by the minimisation method using MINIM software, version
1.5 (www-users.york.ac.uk/∼mb55/guide/minim.htm).
Data were expressed as means±SD unless otherwise stated.
Variables not normally distributed were analysed after logarith-
mic transformation (Log10). The differences in baseline char-
acteristics between the four groups were analysed by ANOVA
and post hoc analysis (least significant difference [LSD] test).
The effects on absolute changes (8 weeks minus baseline) of
dietary polyphenols, dietary LCn3, and the interaction between
polyphenols and LCn3 were evaluated by two-factor ANOVA
adjusting for baseline values. The effects of dietary treatments
on post-challenge profiles (OGTT, test meal) were evaluated
by general linear model for repeated measures.
Statistical analysis was performed according to standard
methods using the Statistical Package for Social Sciences soft-
ware 21.0 (SPSS/PC; SPSS, Chicago, IL, USA).
Results
Seventy-eight participants completed the trial (Control, n=20;
High LCn3, n=19; High PP, n=20; High LCn3&PP, n=19).
Data of the final OGTTwere not available for one individual
in the High PP group owing to technical problems.
At baseline, participants allocated to the four intervention
groups were comparable for age, body weight, BMI, BP,
fasting plasma concentrations of lipids, glucose, insulin and
GLP-1, and fasting insulin sensitivity calculatedwithQUICKI
(Table 1).
At baseline, 25 participants had impaired fasting glucose
(IFG; Control, n=5; High LCn3, n=6; High PP, n=6; High
PP&LCn3, n=8); eight participants had impaired glucose tol-
erance (IGT; Control, n=1; High LCn3, n=4; High PP, n=2;
High PP&LCn3, n=1); and 18 participants had IFG+IGT
(Control, n=4; High LCn3, n=5; High PP, n=7; High
PP&LCn3, n=2).
Compliance to dietary intervention and anthropometrics
measures
As previously reported [20], compliance to the experimental
diets was optimal in all groups. In fact, all participants were
within the ranges of intakes defined for good compliance
(±20% of assigned intake).
Body weight did not change after the intervention except
for a small but statistically significant reduction in the High
LCn3 group (−1.14±1.3 kg) compared with baseline (p=
0.041); waist circumference did not change significantly dur-
ing the intervention [20].
Fasting indices of glucose metabolism
The 8 week intervention with polyphenols, LCn3 or their
combination did not induce any significant change in fasting
plasma concentrations of glucose and insulin, and fasting in-
dices of insulin sensitivity and insulin secretion capacity
(Table 2).
Glucose, insulin and derived indices during OGTT
Glucose and insulin concentrations The absolute changes
after the intervention (8 week minus baseline) in OGTT plas-
ma glucose and insulin mean values are reported either as
single time points (Fig. 1a and c) or as AUC (Fig. 1b and d).
Individual changes in glucose and insulin AUCs are reported
in electronic supplementary material (ESM) Fig. 1. Polyphe-
nols significantly decreased the glycaemic response to glucose
load as shown by absolute changes in total blood glucose
AUC (Control, 1.67±3.56; High LCn3, 0.94±3.56; High PP,
−0.89±3.56; High LCn3&PP, 0.17±4.11 mmol/l 3 h; mean±
SD; p=0.036 for polyphenol effect by two-factor ANOVA),
whereas no significant effect for LCn3s or their interaction
was found. The glucose lowering effect of the polyphenol
enriched diet was more marked in the second part of the
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OGTT (90–120 min; p=0.025 for the time×polyphenol inter-
action by general linear model for repeated measures).
Figure 1c, d reports the results of plasma insulin during
OGTT: no significant difference in total plasma insulin responses
(AUC 0–180 min) was observed among the different diets.
Insulin secretion The early phase of insulin secretion (AUC
0–30 min; Fig. 2a) was significantly increased in the High PP
groups (p=0.048 by two-factor ANOVA) while there was no
effect for LCn3s or their interactions.
Beta cell function Absolute changes in beta cell function are
shown in Fig. 2b. This index of insulin secretion was increased
in the High PP group and decreased in the High LCn3 and
High LCn3&PP groups. By two-factor ANOVA, only the ef-
fect of LCn3was significant (p=0.031), whereas no significant
effects for polyphenols or their interactions were found.
Insulin sensitivity Insulin sensitivity during OGTTevaluated
by OGIS was not significantly different among the dietary
intervention groups according to two-factor ANOVA. By
comparing each group with the control, the High PP group
had a significantly higher increase in insulin sensitivity than
the Control diet group (Fig. 2c; p=0.050 vs Control diet by
post hoc ANOVA).
Glucose, insulin and GLP-1 during the test meal
The absolute changes after the intervention (8 week minus
baseline) in plasma glucose, insulin and GLP-1 during the test
meal are reported in Fig. 3, either as single time points or
AUC. No significant differences in plasma glucose postpran-
dial AUCs were observed. However, postprandial plasma glu-
cose concentrations tended to increase after the LCn3 rich
diets reaching statistical significance at 120 min (Fig. 3a).
Postprandial insulin AUC showed a non-significant increase
after High LCn3&PP and non-significant decreases after both
High LCn3 and High PP (Fig. 3d). High LCn3 decreased
postprandial plasma GLP-1 concentrations with significant
differences in absolute changes at 30, 60, 120 and 180 min
time points (Fig. 3e) and total AUC (Control, 122±351; High
LCn3, −147±206; High PP, −15±289; High LCn3&PP, −239
±322 pmol/l 3 h; p<0.0001 for LCn3 effect by two-factor
ANOVA; Fig. 3f). No significant effect for polyphenols or
their interaction was found (Fig. 3f and e).
Discussion
The main and most relevant finding of our study was that diets
naturally rich in polyphenols reduced plasma glucose concen-
trations and increased the early phase of insulin secretion in
response to an OGTT. Moreover, with the polyphenol-rich
diet, an improvement of post-challenge insulin sensitivity
was also observed.
Recent intervention studies showed that the adhesion to a
healthy Nordic diet [28] has some beneficial effects on glu-
cose metabolism and that the Mediterranean diet [29] reduces
the incidence of CVD and prevents type 2 diabetes. These
beneficial dietary patterns consisted of multiple dietary
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changes with potential favourable effects on glucose metabo-
lism and cardiovascular risk factors, such as a reduction in
saturated fat, an increase in monounsaturated and polyunsat-
urated fatty acids, fibre and polyphenols. Therefore, these ex-
perimental approaches, although giving clinically relevant ev-
idence, do not provide information on how and to what extent
each dietary component beneficially acts. The present study
shows that a diet naturally rich in polyphenols deriving from
different foods and beverages, independently of the other di-
etary components, has favourable effects on glucose
metabolism in people at high risk of diabetes, suggesting that
the metabolic benefits associated with some dietary patterns
may be due, among other factors, to their polyphenol content.
Our results show an improvement in glucose metabolism
during an OGTT and therefore in the absence of an acute
intake of polyphenols. This suggests that the chronic intake
of polyphenols induces long lasting modifications of the met-
abolic and genetic pathways involved in the regulation of
glucose metabolism. In particular, the decrease in plasma glu-
cose concentrations observed during the OGTT was
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associated with an improvement of the first-phase of insulin
secretion. Moreover, as shown by OGTT-related indices, die-
tary polyphenols tended to improve also post-challenge insu-
lin sensitivity. Evidence from several in vitro and animal stud-
ies supports the mechanisms of beneficial action of polyphe-
nols on glucose metabolism observed in our study. In different
experimental settings, various polyphenol classes were able to
enhance insulin secretion both through glucose dependent
[30] and independent [31] mechanisms and by stimulating
beta cell proliferation [32].
Some studies have also shown that polyphenols might im-
prove glucose uptake from peripheral tissues directly influenc-
ing the action of key regulating genes such as peroxisome
proliferator-activated receptor γ (PPAR-γ) and the transloca-
tion of the glucose-transporter GLUT-4 as shown in cultured
adipocytes [33].
In our intervention, the use of different classes of polyphe-
nols, each with a possible different mechanism of action on
glucose metabolism, may explain the simultaneous influence
on different mechanisms, first-phase insulin secretion and in-
sulin sensitivity with a subsequent additive and clearly bene-
ficial effect on glucose tolerance.
The beneficial effects of diets higher in polyphenols on
glucose metabolism observed during OGTTwere not evident
after a meal with the same composition as the followed diet. It
is possible that the test meals—which were poor in carbohy-
drate and rich in fat in order to evaluate an adequate postpran-
dial lipid response—were not optimal to elicit differences in
postprandial glucose response.
We also observed that diets with higher amounts of fish,
rich in LCn3, reduced beta cell function as measured by
OGTT-derived indices, without influencing insulin sensitivity.
This was in line with the tendency to higher glucose and lower
insulin levels after the test meal. These lower insulin levels
were not evident after the combined High LCn3&PP diet,
suggesting that polyphenols intake may blunt the deleterious
effect on insulin secretion of LCn3.
Previous studies with different experimental designs ex-
plored the effects of LCn3 on glucose metabolism giving con-
flicting results [13, 34–36]. Therefore, the pathophysiological
interpretation of our findings on insulin secretion is not univ-
ocal as it might be both the consequence of lipotoxicity due to
the exposure to high concentrations of fatty acids, in particular
LCn3, as shown by in vitro studies [36, 37], but also a phys-
iological mechanism of preservation of beta cell function [36].
In this respect, an interesting finding of our study is that, in
line with data from an acute study [38], the dietary interven-
tion with LCn3 reduced the postprandial GLP-1 response. It
is, therefore, possible that this effect of LCn3 observed after
the test meal may be related to the decrease in beta cell func-
tion found after the glucose challenge.
As for clinical implications, the results of this study are
relevant as they show, for the first time, that a diet containing
foods rich in polyphenols may beneficially influence glucose
metabolism in individuals at high risk of diabetes. Therefore,
an increase in the intake of foods naturally rich in poly-
phenols should be recommended in these individuals to
improve their cardiometabolic profile. The amount of
polyphenols used in our study was higher compared
with the amount generally consumed in western diets
(1 g/day) [39] but is easily reached with natural foods
typical of our as well other gastronomic backgrounds
and without any kind of supplement. Moreover, the very
good adherence of participants shows that this type of
diet is feasible and easily acceptable. A further strength
of our controlled study was that the experimental diets
differed in particular in the two components that we
aimed to evaluate, i.e. polyphenols and LCn3. There-
fore, we can state that, to the best of current knowledge,
the effects on glucose metabolism appear attributable to the
different polyphenols content in the study diets. However, a
possible role of other known or unknown factors such as trace
elements (e.g. copper) cannot be excluded.
A limitation of our study is that participants were
characterised by a high cardiometabolic risk; therefore, we
do not know whether the same results would also apply to a
‘healthy’ population, although no evidence is against this
hypothesis.
In conclusion, this randomised controlled trial provided
evidence that a diet based on different foods and beverages
naturally rich in polyphenols improves glucose metabolism in
individuals at high risk of diabetes and CVD. Therefore, the
best diet for the prevention of diabetes, in addition to the other
well-known characteristics, should be rich also in these bioac-
tive components, which are easily found in foods typical of
different traditional healthy gastronomic backgrounds (Medi-
terranean, Nordic, Asian). A diet with higher amounts of fish,
rich in LCn3, did not lead to evident benefits on glucose me-
tabolism. Studies with a longer follow-up are needed to eval-
uate the real impact of these kinds of diet on the incidence of
diabetes.
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